Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests
November 11, 2014 · No comments
A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.
Ebola Highlights Disparity of Disease Burden in Developed vs. Developing Countries
October 15, 2014 · Comments Off
Study of skin conditions shows mortality rates for measles, syphilis, Ebola hundreds of times higher in developing countries than in developed countries. Study writes that findings, "Highlight the importance of monitoring disease burden in the developing world even when the burden is low."
Study of Dermatology on YouTube Shows New Ways Science Reaches Public
July 9, 2014 · Comments Off
A CU Cancer Center study published in the Dermatology Online Journal shows that YouTube also allows researchers, journals, and health advocates to connect directly with the public on topics of skin cancer and prevention.
May is Skin Cancer Awareness Month: A Conversation with Dr. Neil Box
May 19, 2014 · Comments Off
Neil Box, PhD, is an assistant professor in the Department of Dermatology. In this interview...
Study: Beauty Not Disease Motivates Teens to Wear Sunscreen
February 13, 2014 · Comments Off
"You can tell that when we talk [to teens] about the skin cancer risk, it doesn’t faze them. But when you talk about premature wrinkling and aging, they listen a little more closely," says April W. Armstrong, MD MPH, investigator at the CU Cancer Center.
AACR News: New target plus new drug equals death of melanoma cells
April 9, 2013 · Comments Off
Research presented at the American Association for Cancer Research (AACR) Annual Conference, shows that the protein receptor Mer is overexpressed in melanoma and that the investigational drug UNC1062 blocks Mer survival signaling in these cells, killing them.
Serendipity points to new potential target and therapy for melanoma
December 20, 2012 · 2 comments
MicroRNA can decide which genes in a cell's DNA are expressed and which stay silent. Melanoma tends to lack microRNA-26a, which makes the gene SODD go silent. This silence creates cancer and may be instrumental in its cure.
Parents’ skin cancer concern doesn’t keep kids inside
September 6, 2012 · Comments Off
Pick your poison: sun exposure that leads to skin cancer or low physical activity that leads to obesity? In fact, a University of Colorado Cancer Center study published this week in the journal Preventing Chronic Disease shows that parents' concern about skin cancer doesn't make them keep their kids indoors.
Study identifies human melanoma stem cells
August 23, 2012 · Comments Off
Cancer stem cells are defined by three abilities: differentiation, self-renewal and their ability to seed...
NTRK1: a new oncogene and target in lung cancer
August 23, 2012
“Dramatic” Early Phase 1 Results for AG-120 in IDH1 Mutated AML
November 24, 2014 · No comments
University of Colorado Hospital Now Offering Lung Cancer Screening
November 13, 2014 · No comments
CU Cancer Center brings specialty care to Colorado
November 12, 2014 · No comments
ALK amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer clinical trials cancer grants cancer research colorado cancer stem cells Cancer Survivorship clinical trial colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer Thomas Flaig tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith